CA2421258C - Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques - Google Patents

Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques Download PDF

Info

Publication number
CA2421258C
CA2421258C CA2421258A CA2421258A CA2421258C CA 2421258 C CA2421258 C CA 2421258C CA 2421258 A CA2421258 A CA 2421258A CA 2421258 A CA2421258 A CA 2421258A CA 2421258 C CA2421258 C CA 2421258C
Authority
CA
Canada
Prior art keywords
polypeptide
protein
bard1
leu
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2421258A
Other languages
English (en)
French (fr)
Other versions
CA2421258A1 (fr
Inventor
Fabien Gautier
Jean Harb
Khaled Meflah
Irmgard Irminger-Finger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ayanda Biosystems SA
Original Assignee
Ayanda Biosystems SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayanda Biosystems SA filed Critical Ayanda Biosystems SA
Publication of CA2421258A1 publication Critical patent/CA2421258A1/fr
Application granted granted Critical
Publication of CA2421258C publication Critical patent/CA2421258C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2421258A 2000-09-01 2001-09-03 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques Expired - Fee Related CA2421258C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0011207A FR2813606B1 (fr) 2000-09-01 2000-09-01 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
FR00/11207 2000-09-01
PCT/FR2001/002731 WO2002018536A2 (fr) 2000-09-01 2001-09-03 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques

Publications (2)

Publication Number Publication Date
CA2421258A1 CA2421258A1 (fr) 2002-03-07
CA2421258C true CA2421258C (fr) 2011-04-19

Family

ID=8853916

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2421258A Expired - Fee Related CA2421258C (fr) 2000-09-01 2001-09-03 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques

Country Status (8)

Country Link
US (2) US7566764B2 (enExample)
EP (1) EP1313855B1 (enExample)
JP (1) JP4995399B2 (enExample)
AT (1) ATE328082T1 (enExample)
CA (1) CA2421258C (enExample)
DE (1) DE60120187T2 (enExample)
FR (1) FR2813606B1 (enExample)
WO (1) WO2002018536A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2681360A1 (en) * 2007-04-02 2008-10-09 Universite De Geneve Deletion bearing bard1 isoforms and use thereof
SG10201506437PA (en) * 2010-08-17 2015-10-29 Univ Geneve BARD1 Isoforms in Lung and Colorectal Cancer and Use Thereof
MX2016005686A (es) 2013-10-31 2016-08-11 Regeneron Pharma Ensayo de union competitiva al ligando para detectar anticuerpos neutralizantes.
EP2871480A1 (en) * 2013-11-06 2015-05-13 Bard1Ag SA Lung Cancer Diagnosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4586697A (en) * 1996-09-20 1998-04-14 Board Of Regents, The University Of Texas System Compositions and methods comprising bard1 and other brca1 binding proteins
EP1179541B1 (en) * 1999-04-28 2004-06-16 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting VEGF

Also Published As

Publication number Publication date
ATE328082T1 (de) 2006-06-15
JP2004518410A (ja) 2004-06-24
DE60120187D1 (de) 2006-07-06
EP1313855A2 (fr) 2003-05-28
DE60120187T2 (de) 2007-03-29
FR2813606A1 (fr) 2002-03-08
US7566764B2 (en) 2009-07-28
JP4995399B2 (ja) 2012-08-08
EP1313855B1 (fr) 2006-05-31
FR2813606B1 (fr) 2004-04-30
WO2002018536A3 (fr) 2003-01-03
US20040234959A1 (en) 2004-11-25
CA2421258A1 (fr) 2002-03-07
WO2002018536A2 (fr) 2002-03-07
US20100016228A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
US7906620B2 (en) Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
US20050019304A1 (en) Novel human mage-like protein
HUP0004022A2 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
JP5502253B2 (ja) 新規化合物
CA2283107A1 (en) A tm4sf human tumor-associated antigen
AU2003262266A1 (en) Drugs containing galectin 9
EP0793721B1 (fr) Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
JP2003508011A (ja) ヒトｆｅｚ１遺伝子である新規ガン抑制遺伝子に関する組成物、キットおよび方法
EP0877758A2 (fr) PROTEINE PURIFIEE SR-p70
EP1313855B1 (fr) Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
CA2343720A1 (en) Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies
US6281190B1 (en) Human LEA-motif developmental protein
JP2002503962A (ja) ヒトタンパク質フォスファターゼ▲ｉｉ▼−ｃ様タンパク質
FR2821624A1 (fr) Nouveau polynucleotide utilisable pour moduler la proliferation des cellules cancereuses
US5851987A (en) Human tumor-associated Kazal inhibitor-like polypeptides and encoding polynucleotides
JP2001515352A (ja) タンパク質キナーゼｃインヒビタ様タンパク質（ｉｐｋｃ−２）
CA2465639A1 (en) Tumor antigen
JP2001521385A (ja) ヒト腫瘍関連膜タンパク質
JP2001503629A (ja) Ｐｅｃ―６０との相同性を有する腫瘍関連ｋａｚａｌ型インヒビター
CA2509422A1 (fr) Procede de preparation d'heterocarpine recombinante
JPWO1998042744A1 (ja) 細胞死抑制蛋白質
CN103059110A (zh) 白念珠菌细胞凋亡促进因子基因及其用途

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140903